Assessing the Predictive Value of JAK2 V617F Allele Burden in Non-CML Classical Subtypes of Myeloproliferative Neoplasms

被引：0
|
作者：
Gober-Wilcox, Julie [1 ]
Vennapusa, Bharathi [1 ]
Pierce, Joseph [2 ]
Vasef, Mohammad A. [1 ,2 ]
机构：
[1] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA
[2] TriCore Reference Lab, Albuquerque, NM USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2009年 / 132卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
28
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [1] JAK2 V617F Allele Burden in Non-CML Classical Subtypes of Myeloproliferative Neoplasms (MPN)
    Gober-Wilcox, J.
    Vennapusa, B.
    Pierce, J.
    Vasef, M. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 581 - 581
  • [2] JAK2 V617F ALLELE BURDEN IN CHRONIC MYELOPROLIFERATIVE DISEASES
    Skerget, Matevz
    Pajic, Tadej
    Kralj, Eva
    Vuckovic, Josko
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I57 - I61
  • [3] The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis
    Goodyer, Matthew
    Langabeer, Stephen E.
    Haslam, Karl
    Murphy, Karen
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (01) : 229 - 230
  • [4] JAK2 V617F Mutation Allele Burden (MAB) and Its Correlation with Hematologic Characteristics in Myeloproliferative Neoplasms
    Kim, David Y.
    Tariq, Hamza
    Brown, Alan F.
    Vadlamudi, Kumari
    Wang, Yao
    Ikoma, Shohei
    Holder, Kenneth N.
    Higgins, Russell A.
    Fan, Hongxin
    BLOOD, 2017, 130
  • [5] The JAK2 V617F mutational status and allele burden
    Liang, Shanshan
    Zhou, Yanhong
    THROMBOSIS RESEARCH, 2015, 136 (03) : 690 - 690
  • [6] JAK2 V617F Impairs Lymphoid Differentiation in Myeloproliferative Neoplasms
    Choi, Daniel C.
    Abu-Zeinah, Ghaith
    Kermani, Pouneh
    Messali, Nassima
    Yabut, Maria Mia
    Erdos, Katie
    Scandura, Joseph M.
    BLOOD, 2023, 142
  • [7] Megakaryocytic nuclear phospho-STAT5 staining in non-CML myeloproliferative disorders correlates with JAK2 V617F
    Aboudola, S
    Szpurka, H
    Murugesan, G
    Maciejewski, JP
    Tubbs, RR
    Prescott, NL
    Verbic, MA
    Hsi, ED
    MODERN PATHOLOGY, 2006, 19 : 214A - 214A
  • [8] Correlation of JAK2 V617F Mutation Burden with Clinical and Hematologic Characteristics of Myeloproliferative Neoplasms
    Brown, A. F.
    Wang, Y.
    Abu-Ghusson, M. M.
    George, P. A.
    Vadlamudi, K.
    Furmaga, W. B.
    Fan, H.
    MODERN PATHOLOGY, 2013, 26 : 321A - 321A
  • [9] Correlation of JAK2 V617F Mutation Burden with Clinical and Hematologic Characteristics of Myeloproliferative Neoplasms
    Brown, A. F.
    Wang, Y.
    Abu-Ghusson, M. M.
    George, P. A.
    Vadlamudi, K.
    Furmaga, W. B.
    Fan, H.
    LABORATORY INVESTIGATION, 2013, 93 : 321A - 321A
  • [10] The clinical value of plasma CFDNA JAK2 V617F mutation detection in myeloproliferative neoplasms
    Wu, Q.
    Cao, G.
    Guan, M.
    CLINICA CHIMICA ACTA, 2024, 558
12345